VCYT: Veracyte, Inc. Stock

by  •  • Comments Off on VCYT: Veracyte, Inc. Stock

SIC 8071 – Medical Laboratories

Valuation
Market Cap ($M) 1,554.94
Enterprise Value ($M) 1,338.49
Book Value ($M) 1,044.10
Book Value / Share 13.66
Price / Book 1.49
NCAV ($M) 214.82
NCAV / Share 2.81
Price / NCAV 7.24

Profitability (mra)
Return on Invested Capital (ROIC) -0.07
Return on Assets (ROA) -0.06
Return on Equity (ROE) -0.07

Liquidity (mrq)
Quick Ratio 4.40
Current Ratio 4.66

Balance Sheet (mrq) ($M)
Current Assets 285.62
Assets 1,114.91
Liabilities 70.80
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 361.05
Operating Income -14.27
Net Income -74.40
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 44.22
Cash from Investing 15.11
Cash from Financing 2.84

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-13 13G/A Vanguard Group Inc 9.75 3.88
02-12 13G/A Artisan Partners Limited Partnership 4.40 -14.45
02-08 13G/A Wellington Management Group Llp 9.68 -2.49
01-29 13G/A ARK Investment Management LLC 10.48 -7.77
01-24 13G/A BlackRock Inc. 9.80 9.60
01-22 13G/A State Street Corp 4.26 -25.26

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-29 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K
2023-11-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-05-05 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-30 93,363 261,266 35.73
2024-04-29 117,115 252,362 46.41
2024-04-26 145,370 281,415 51.66

(click for more detail)

Similar Companies
PSNL – Personalis, Inc. RDNT – RadNet, Inc.
SERA – Sera Prognostics, Inc.


Financial data and stock pages provided by
Fintel.io